Cambridge Pharma Consultancy — 17 certified H-1B filings (FY2020–FY2025)
- 1
- Filings · FY2025
- $215k
- Median base · FY2025
- Manager, Strategy/Life Sciences Consulting
- Top role · 3 all-time
- NY
- Top state · 15 all-time
Cambridge Pharma Consultancy filed 1 certified H-1B LCAs in FY2025, with a median base salary of $215k and the middle 50% of offers between $215k and $215k. Across all years it has 17 certified filings since FY2020, most often for Manager, Strategy/Life Sciences Consulting in New York.
How much does Cambridge Pharma Consultancy pay H-1B workers?
Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $215k median in FY2025. Base pay only — hover a year for its figures.
How has Cambridge Pharma Consultancy's H-1B hiring changed by year?
4 certified filings in FY2020 → 1 in FY2025. The change column is each year against the one before.
| Fiscal year | Filings | vs prior FY | Median base |
|---|---|---|---|
| FY2025 | 1 | 0% | $215k |
| FY2024 | 1 | −50% | $90k |
| FY2023 | 2 | −33% | $88k |
| FY2022 | 3 | −50% | $165k |
| FY2021 | 6 | +50% | $95k |
| FY2020 | 4 | — | $150k |
Which wage levels does Cambridge Pharma Consultancy file?
DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 47% of Cambridge Pharma Consultancy's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.
Share of 17 filings with a wage level · all years
- Level I35.3%6
- Level II17.6%3
- Level III11.8%2
- Level IV35.3%6
What jobs does Cambridge Pharma Consultancy sponsor for H-1B?
The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.
| Job title | Filings | Median base |
|---|---|---|
| Manager, Strategy/Life Sciences Consulting | 3 | $160k |
| Associate, Strategy/Life Sciences | 2 | $88k |
| Manager, Strategy/Life Sciences | 2 | $150k |
| Consultant, Strategy/Life Sciences | 2 | $165k |
| Associate Strat/Life Science | 1 | $81k |
| Associate, Strategy/Life Science | 1 | $81k |
| Consultant, Strat/Life Science | 1 | $138k |
| Manager 1, Strategy Life Science | 1 | $150k |
| Associate Consultant 1, Strategy Life Science | 1 | $91k |
| Associate Consultant 1, Strat/Life Science | 1 | $95k |
Where does Cambridge Pharma Consultancy hire H-1B workers?
Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.
| State | Filings | Median base |
|---|---|---|
| NY | 15 | $138k |
| MA | 2 | $196k |
What has Cambridge Pharma Consultancy filed recently?
Every certified LCA on record for Cambridge Pharma Consultancy: job title, worksite, prevailing-wage level and the offered base salary.
| FY | Job title | Base salary |
|---|---|---|
| 2025 | Associate Principal | $215,460 |
| 2024 | Associate, Strategy/Life Sciences | $89,933 |
| 2023 | Consultant, Strategy/Life Sciences | $165,000 |
| 2023 | Associate, Strategy/Life Sciences | $87,500 |
| 2022 | Manager, Strategy/Life Sciences | $195,800 |
| 2022 | Consultant, Strategy/Life Sciences | $165,000 |
| 2022 | Associate Consultant 2, Strategy/ Life Sciences | $115,000 |
| 2021 | Associate Consultant 1, Strat/Life Science | $95,000 |
| 2021 | Manager, Strategy/Life Sciences Consulting | $160,000 |
| 2021 | Associate Strat/Life Science | $81,000 |
| 2021 | Manager, Strategy/Life Sciences | $150,000 |
| 2021 | Consultant, Strat/Life Science | $138,000 |
| 2021 | Associate, Strategy/Life Science | $81,000 |
| 2020 | Manager, Strategy/Life Sciences Consulting | $160,000 |
| 2020 | Manager, Strategy/Life Sciences Consulting | $150,000 |
| 2020 | Associate Consultant 1, Strategy Life Science | $91,000 |
| 2020 | Manager 1, Strategy Life Science | $150,000 |
Common questions about Cambridge Pharma Consultancy's H-1B filings
- How much does Cambridge Pharma Consultancy pay H-1B workers?
- Cambridge Pharma Consultancy's median certified H-1B base salary is $215k (FY2025), from 1 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Cambridge Pharma Consultancy sponsor?
- Cambridge Pharma Consultancy has 17 certified H-1B Labor Condition Applications on record (FY2020–FY2025).
- What jobs does Cambridge Pharma Consultancy sponsor for H-1B?
- Cambridge Pharma Consultancy's most-sponsored H-1B roles include Manager, Strategy/Life Sciences Consulting, Associate, Strategy/Life Sciences, Manager, Strategy/Life Sciences, Consultant, Strategy/Life Sciences.
- Where does Cambridge Pharma Consultancy hire H-1B workers?
- Cambridge Pharma Consultancy's top H-1B worksite states are NY, MA.
- Does a certified LCA mean an H-1B visa was approved?
- No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
- What salary do these figures show?
- The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
- What do prevailing-wage levels I–IV mean?
- The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.
Keep exploring
Calculate your H-1B lottery odds →orCheck out the insights →
Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2020–FY2025). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →